Nobuyuki Arakawa, CEO of Celaid Therapeutics Inc., will speak at Investor Day Japan 2026, co-hosted by iCONM in collaboration with BioLabs, Astellas Pharma Inc., the Life Science Innovation Network Japan (LINK-J), and BioLabs (U.S.), on March 19, 2026.
This event provides an opportunity for early- to mid-stage drug discovery startups to present their drug discovery stories to investors and industry experts from Japan and around the world. In addition to pitch presentations by startups, the program will feature two panel discussions focusing on collaboration with pharmaceutical companies and the growth of drug discovery businesses.